PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Thursday reported a loss of $18.6 million in its third quarter.
The Palo Alto, California-based company said it had a loss of 76 cents per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 77 cents per share.
Eiger BioPharma shares have risen slightly more than 6% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.80, a decline of 9% in the last 12 months.